Tulin AV - Search Results

1

Poly(ADP)-Ribosylation Inhibition: A Promising Approach for Clear Cell Renal Cell Carcinoma Therapy.

Karpova Y, Guo D, Makhov P, Haines AM, Markov DA, Kolenko V, Tulin AV. Karpova Y, et al. Among authors: tulin av. Cancers (Basel). 2021 Oct 3;13(19):4973. doi: 10.3390/cancers13194973. Cancers (Basel). 2021. PMID: 34638458 Free PMC article.

2

Piperlongumine promotes autophagy via inhibition of Akt/mTOR signalling and mediates cancer cell death.

Makhov P, Golovine K, Teper E, Kutikov A, Mehrazin R, Corcoran A, Tulin A, Uzzo RG, Kolenko VM. Makhov P, et al. Br J Cancer. 2014 Feb 18;110(4):899-907. doi: 10.1038/bjc.2013.810. Epub 2014 Jan 16. Br J Cancer. 2014. PMID: 24434432 Free PMC article.

3

Minor grove binding ligands disrupt PARP-1 activation pathways.

Kirsanov KI, Kotova E, Makhov P, Golovine K, Lesovaya EA, Kolenko VM, Yakubovskaya MG, Tulin AV. Kirsanov KI, et al. Among authors: tulin av. Oncotarget. 2014 Jan 30;5(2):428-37. doi: 10.18632/oncotarget.1742. Oncotarget. 2014. PMID: 24504413 Free PMC article.

4

Piperlongumine and its analogs down-regulate expression of c-Met in renal cell carcinoma.

Golovine K, Makhov P, Naito S, Raiyani H, Tomaszewski J, Mehrazin R, Tulin A, Kutikov A, Uzzo RG, Kolenko VM. Golovine K, et al. Cancer Biol Ther. 2015;16(5):743-9. doi: 10.1080/15384047.2015.1026511. Cancer Biol Ther. 2015. PMID: 25801713 Free PMC article.

5

Charon Mediates Immune Deficiency-Driven PARP-1-Dependent Immune Responses in Drosophila.

Ji Y, Thomas C, Tulin N, Lodhi N, Boamah E, Kolenko V, Tulin AV. Ji Y, et al. Among authors: tulin n, tulin av. J Immunol. 2016 Sep 15;197(6):2382-9. doi: 10.4049/jimmunol.1600994. Epub 2016 Aug 15. J Immunol. 2016. PMID: 27527593 Free PMC article.

6

Non-NAD-Like poly(ADP-Ribose) Polymerase-1 Inhibitors effectively Eliminate Cancer in vivo.

Thomas C, Ji Y, Lodhi N, Kotova E, Pinnola AD, Golovine K, Makhov P, Pechenkina K, Kolenko V, Tulin AV. Thomas C, et al. Among authors: tulin av. EBioMedicine. 2016 Nov;13:90-98. doi: 10.1016/j.ebiom.2016.10.001. Epub 2016 Oct 4. EBioMedicine. 2016. PMID: 27727003 Free PMC article.

7

LDL cholesterol counteracts the antitumour effect of tyrosine kinase inhibitors against renal cell carcinoma.

Naito S, Makhov P, Astsaturov I, Golovine K, Tulin A, Kutikov A, Uzzo RG, Kolenko VM. Naito S, et al. Br J Cancer. 2017 Apr 25;116(9):1203-1207. doi: 10.1038/bjc.2017.77. Epub 2017 Mar 28. Br J Cancer. 2017. PMID: 28350788 Free PMC article.

8

Non-NAD-like PARP-1 inhibitors in prostate cancer treatment.

Karpova Y, Wu C, Divan A, McDonnell ME, Hewlett E, Makhov P, Gordon J, Ye M, Reitz AB, Childers WE, Skorski T, Kolenko V, Tulin AV. Karpova Y, et al. Among authors: tulin av. Biochem Pharmacol. 2019 Sep;167:149-162. doi: 10.1016/j.bcp.2019.03.021. Epub 2019 Mar 15. Biochem Pharmacol. 2019. PMID: 30880062 Free PMC article.

9

Histone-dependent PARP-1 inhibitors: A novel therapeutic modality for the treatment of prostate and renal cancers.

Makhov P, Uzzo RG, Tulin AV, Kolenko VM. Makhov P, et al. Among authors: tulin av. Urol Oncol. 2021 Jun;39(6):312-315. doi: 10.1016/j.urolonc.2020.04.004. Epub 2020 May 8. Urol Oncol. 2021. PMID: 32402770 Free PMC article. Review.

10

Poly(ADP-ribose) polymerase 1 in genome-wide expression control in Drosophila.

Bordet G, Lodhi N, Guo D, Kossenkov A, Tulin AV. Bordet G, et al. Among authors: tulin av. Sci Rep. 2020 Dec 3;10(1):21151. doi: 10.1038/s41598-020-78116-5. Sci Rep. 2020. PMID: 33273587 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

66 results

Search Page